Skip to main content
. 2020 Jul 13;369(6507):1119–1123. doi: 10.1126/science.abd2321

Fig. 1. Structures of two IGHV3-53 antibodies.

Fig. 1

(A) The distribution of IGHV gene usage is shown for a total of 294 RBD-targeting antibodies (1728). (B to D) Crystal structures of (B) CC12.1 in complex with SARS-CoV-2 RBD, (C) CC12.3 with SARS-CoV-2 RBD, and (D) human ACE2 with SARS-CoV-2 RBD (PDB 6M0J) (12).